(Q39791590)

14 September 2017

1 reference

title

Advances in the treatment of acute myelogenous leukemia (English)

1 reference

14 September 2017

Advances in the Treatment of Acute Myelogenous Leukemia (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

1 reference

R. P. Gale

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A372809

10 April 2023

language of work or name

English

0 references

publication date

1 May 1979

1 reference

14 September 2017

24 May 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=372809

full work available at URL

10 April 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197905243002105

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The New England Journal of Medicine

10 April 2023

published in

1 reference

14 September 2017

300

1 reference

14 September 2017

21

1 reference

14 September 2017

1189-1199

1 reference

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

14 September 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Classification of Acute Leukemia

10 April 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The natural history of untreated acute leukemia

10 April 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Comparison of methotrexate with 6-mercaptopurine–prednisone in treatment of acute leukemia in adults

10 April 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The role of vincristine in the treatment of childhood acute leukemia

10 April 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Predinsome therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients

10 April 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

14

8

120

Bergsagel

1960

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

15

8

106

Shnider

1960

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

16

16

167

Hoogstraten

1962

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors

10 April 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

L-Asparaginase

18

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Treatment of Acute Leukemia

10 April 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

20

15

336

Henderson

1967

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

POMP combination chemotherapy of adult acute leukemia

10 April 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The clinical pharmacology of antineoplastic agents (first of two parts).

10 April 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

24

51

125

Skipper

1967

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Prolonged infusion of arabinosyl cytosine in childhood leukemia

10 April 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

10 April 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Treatment of adult acute leukemia with arabinosylcytosine and thioguanine

10 April 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Treatment of acute leukemia in adults

10 April 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party

10 April 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia

10 April 2023

34

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

36

56

543

Whitecar

1972

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation

10 April 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

40

60

41

Wiernik

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Treatment of acute myeloid leukaemia with cytosine arabinoside and daunomycin in combination

10 April 2023

41

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia

10 April 2023

42

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Management of adult acute myelogenous leukaemia.

10 April 2023

43

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

46

59

1131

Glucksberg

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

High remission-induction rate in acute myeloid leukaemia

10 April 2023

47

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Relevance of the Cytogenetic Status in Acute Leukemia in Adults2

10 April 2023

50

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Reverse Transcriptase in Leukocytes of Leukemic Patients in Remission

10 April 2023

51

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Cell kinetics and practical consequences for therapy of acute leukemia

10 April 2023

53

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Prolonged maintained remissions of adult acute non-lymphocytic leukaemia

10 April 2023

56

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Prolonged remission maintenance in acute myeloid leukaemia.

10 April 2023

57

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The incidence of central nervous system leukemia in adults with acute leukemia

10 April 2023

58

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Neurological Complications of Acute Leukemia in Adults: Changing Rate

10 April 2023

59

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Adult acute leukemia.Frequency of central nervous system involvement in long term survivors

10 April 2023

60

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Therapy of acute myelogeneous leukemia

10 April 2023

63

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Immunotherapy in the management of acute leukaemia

10 April 2023

65

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

Immunotherapy of cancer

68

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin

10 April 2023

69

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Immunotherapy for acute myelogenous leukaemia

10 April 2023

70

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

10 April 2023

71

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient

10 April 2023

75

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cells

10 April 2023

76

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

British Journal of Cancer

10 April 2023

77

34

612

Peto

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

10 April 2023

78

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Infection and second-remission rates in patients having immunotherapy for acute myeloid keukemia

10 April 2023

79

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The Immunotherapy of Acute Myelogenous Leukaemia using Intravenous BCG

10 April 2023

80

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults with acute nonlymphocytic leukemia

10 April 2023

82

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia

10 April 2023

84

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

85

61

915

Omura

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

86

61

1599

Van Echo

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

VP 16-213 in acute myelogenous leukaemia

10 April 2023

89

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies

10 April 2023

91

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

92

61

905

Wilson

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

95

59

385

Geiser

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Clinical studies of beta-thioguanine deoxyriboside alone and in combination with arabinosyl cytosine

10 April 2023

96

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

98

59

647

Hill

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

100

57

459

Higby

1973

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Cis-diamminedichloroplatinum (II). A new anticancer drug

10 April 2023

101

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

102

61

667

Bertino

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Bone-marrow transplantation (first of two parts).

10 April 2023

105

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Bone-Marrow Transplantation for Hematologic Neoplasia in 16 Patients with Identical Twins

10 April 2023

109

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Autologous bone marrow transplantation in patients with adult acute leukemia in relapse

10 April 2023

112

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

113

61

1441

Cassileth

1977

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

114

60

1845

Vogler

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Manipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia

10 April 2023

115

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Prognostic significance of pretreatment proliferative activity in adult acute leukemia

10 April 2023

116

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Human preleukemia. Identification of a maturation defect in vitro

10 April 2023

120

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Non-random chromosome changes in acute myeloid leukemia. Chromosome banding examination of 30 cases at diagnosis

10 April 2023

125

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia

10 April 2023

126

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977).

10 April 2023

127

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Preleukemia. The hematologic syndrome preceding acute leukemia

10 April 2023

130

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

The preleukemic syndrome (hemopoietic dysplasia).

10 April 2023

133

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Nouvelle revue francaise d'hematologie; blood cells

10 April 2023

135

17

33

Dreyfus

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

A new observation in the clinical spectrums of erythroleukemia. A report of 46 cases

10 April 2023

136

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Second neoplasm--a complication of cancer chemotherapy

10 April 2023

139

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

10 April 2023

140

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

10 April 2023

141

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

10 April 2023

142

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Infections in cancer patients

10 April 2023

145

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

10 April 2023

146

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia

10 April 2023

147

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia

10 April 2023

148

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Co-trimoxazole for prevention of infection in acute leukaemia

10 April 2023

149

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

10 April 2023

150

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia

10 April 2023

151

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study

10 April 2023

152

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia

10 April 2023

153

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies

10 April 2023

154

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia

10 April 2023

155

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia

10 April 2023

156

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow Transplants

10 April 2023

157

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Intensive Multiunit Plateletpheresis of Normal Donors

10 April 2023

159

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Frozen autologous platelet transfusion for patients with leukemia

10 April 2023

160

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Some aspects of recent advances in the use of blood cell components

10 April 2023

161

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Prophylactic heparin therapy in acute promyelocytic leukemia

10 April 2023

162

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Quality and quantity of survival in acute myeloid leukaemia

10 April 2023

164

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Cost analysis of leukemia treatment: a problem-oriented approach

10 April 2023

165

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia

10 April 2023

166

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds

10 April 2023

167

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity

10 April 2023

168

1 reference

https://api.crossref.org/works/10.1056/NEJM197905243002105

10 April 2023

Identifiers

1 reference

14 September 2017

1 reference